2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults
Tóm tắt
Từ khóa
Tài liệu tham khảo
Califf, 1996, 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events, J Am Coll Cardiol, 27, 1007, 10.1016/0735-1097(96)87733-3
D'Agostino, 2000, Primary and subsequent coronary risk appraisal: new results from the Framingham Study, Am Heart J, 139, 272, 10.1016/S0002-8703(00)90236-9
Greenland, 2003, Major risk factors as antecedents of fatal and nonfatal coronary heart disease events, JAMA, 290, 891, 10.1001/jama.290.7.891
Ni, 2009, Trends from 1987 to 2004 in sudden death due to coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study, Am Heart J, 157, 46, 10.1016/j.ahj.2008.08.016
Lloyd-Jones, 2009, Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 119, e21
Ford, 2007, Explaining the decrease in U.S. deaths from coronary disease, 1980–2000, N Engl J Med, 356, 2388, 10.1056/NEJMsa053935
McMahan, 2007, Association of Pathobiologic Determinants of Atherosclerosis in Youth risk score and 15-year change in risk score with carotid artery intima-media thickness in young adults (from the Cardiovascular Risk in Young Finns Study), Am J Cardiol, 100, 1124, 10.1016/j.amjcard.2007.05.035
Gidding, 2006, Prediction of coronary artery calcium in young adults using the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) risk score: the CARDIA study, Arch Intern Med, 166, 2341, 10.1001/archinte.166.21.2341
McMahan, 2006, Pathobiological determinants of atherosclerosis in youth risk scores are associated with early and advanced atherosclerosis, Pediatrics, 118, 1447, 10.1542/peds.2006-0970
Lloyd-Jones, 1999, Lifetime risk of developing coronary heart disease, Lancet, 353, 89, 10.1016/S0140-6736(98)10279-9
Lloyd-Jones, 2006, Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age, Circulation, 113, 791, 10.1161/CIRCULATIONAHA.105.548206
Haapanene-Niemi, 2009, Public health burden of coronary disease risk factors among middle-aged and elderly men, Prev. Med, 4, 343
Vinereau, 2006, Risk factors for atherosclerotic disease: present and future, Herz, 31, 5
Hlatky, 2009, Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association, Circulation, 119, 2408, 10.1161/CIRCULATIONAHA.109.192278
von Elm, 2007, The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, Ann Intern Med, 147, 573, 10.7326/0003-4819-147-8-200710160-00010
Greenland, 2005, When is a new prediction marker useful?, Arch Intern Med, 165, 2454, 10.1001/archinte.165.21.2454
Detrano, 2008, Coronary calcium as a predictor of coronary events in four racial or ethnic groups, N Engl J Med, 358, 1336, 10.1056/NEJMoa072100
Kathiresan, 2007, A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study, BMC Med Genet, 8, S17, 10.1186/1471-2350-8-S1-S17
Melander, 2009, Novel and conventional biomarkers for prediction of incident cardiovascular events in the community, JAMA, 302, 49, 10.1001/jama.2009.943
Cook, 2007, Use and misuse of the receiver operating characteristic curve in risk prediction, Circulation, 115, 928, 10.1161/CIRCULATIONAHA.106.672402
Ridker, 2007, Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score, JAMA, 297, 611, 10.1001/jama.297.6.611
Pencina, 2008, Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond, Stat Med, 27, 157, 10.1002/sim.2929
Brindle, 2006, Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review, Heart, 92, 1752, 10.1136/hrt.2006.087932
D'Agostino, 2001, Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation, JAMA, 286, 180, 10.1001/jama.286.2.180
2001, Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), JAMA, 285, 2486, 10.1001/jama.285.19.2486
Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation, 97, 1837, 10.1161/01.CIR.97.18.1837
Friedmann, 1996, Differences in generalists' and cardiologists' perceptions of cardiovascular risk and the outcomes of preventive therapy in cardiovascular disease, Ann Intern Med, 124, 414, 10.7326/0003-4819-124-4-199602150-00005
Grover, 1995, Do doctors accurately assess coronary risk in their patients?, BMJ, 310, 975, 10.1136/bmj.310.6985.975
McManus, 2002, Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study, BMJ, 324, 459, 10.1136/bmj.324.7335.459
Montgomery, 2000, Estimation of cardiovascular risk in hypertensive patients in primary care, Br J Gen Pract, 50, 127
Greenland, 2001, Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests, Circulation, 104, 1863, 10.1161/hc4201.097189
Topol, 2003, The rudimentary phase of personalised medicine: coronary risk scores, Lancet, 362, 1776, 10.1016/S0140-6736(03)14941-0
D'Agostino, 2008, General cardiovascular risk profile for use in primary care: the Framingham Heart Study, Circulation, 117, 743, 10.1161/CIRCULATIONAHA.107.699579
Conroy, 2003, Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, Eur Heart J, 24, 987, 10.1016/S0195-668X(03)00114-3
2002, Prediction of mortality from coronary heart disease among diverse populations: is there a common predictive function?, Heart, 88, 222, 10.1136/heart.88.3.222
Gaziano, 2008, Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort, Lancet, 371, 923, 10.1016/S0140-6736(08)60418-3
Berry, 2007, Framingham risk score and prediction of coronary heart disease death in young men, Am Heart J, 154, 80, 10.1016/j.ahj.2007.03.042
Cavanaugh-Hussey, 2008, Who exceeds ATP-III risk thresholds?, Prev Med, 47, 619, 10.1016/j.ypmed.2008.07.012
Marma, 2009, Systematic examination of the updated Framingham heart study general cardiovascular risk profile, Circulation, 120, 384, 10.1161/CIRCULATIONAHA.108.835470
Yusuf, 2004, Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study, Lancet, 364, 937, 10.1016/S0140-6736(04)17018-9
Ridker, 2002, Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events, N Engl J Med, 347, 1557, 10.1056/NEJMoa021993
Mosca, 2007, Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update, J Am Coll Cardiol, 49, 1230, 10.1016/j.jacc.2007.02.020
Fletcher, 2005, Managing abnormal blood lipids: a collaborative approach, Circulation, 112, 3184, 10.1161/CIRCULATIONAHA.105.169180
Grundy, 2005, Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement, Circulation, 112, 2735, 10.1161/CIRCULATIONAHA.105.169404
Eyre, 2004, Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association, Circulation, 109, 3244, 10.1161/01.CIR.0000133321.00456.00
Grundy, 1998, Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction, Circulation, 97, 1876, 10.1161/01.CIR.97.18.1876
Pencina, 2009, Predicting the 30–year risk of cardiovascular disease: the Framingham Heart Study, Circulation, 119, 3078, 10.1161/CIRCULATIONAHA.108.816694
Assmann, 2002, Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study, Circulation, 105, 310, 10.1161/hc0302.102575
Sesso, 2001, Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women, Circulation, 104, 393, 10.1161/hc2901.093115
Shih, 2008, Hereditary determinants of human hypertension: strategies in the setting of genetic complexity, Hypertension, 51, 1456, 10.1161/HYPERTENSIONAHA.107.090480
Levy, 2000, Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart Study, Hypertension, 36, 477, 10.1161/01.HYP.36.4.477
Weiss, 2006, The sex-specific genetic architecture of quantitative traits in humans, Nat Genet, 38, 218, 10.1038/ng1726
Harrison, 2003, Family history of diabetes as a potential public health tool, Am J Prev Med, 24, 152, 10.1016/S0749-3797(02)00588-3
Coady, 2002, Genetic variability of adult body mass index: a longitudinal assessment in Framingham families, Obes Res, 10, 675, 10.1038/oby.2002.91
Munafo, 2004, The genetic basis for smoking behavior: a systematic review and meta-analysis, Nicotine Tob Res, 6, 583, 10.1080/14622200410001734030
Lloyd-Jones, 2004, Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring, JAMA, 291, 2204, 10.1001/jama.291.18.2204
Murabito, 2005, Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults, JAMA, 294, 3117, 10.1001/jama.294.24.3117
Marenberg, 1994, Genetic susceptibility to death from coronary heart disease in a study of twins, N Engl J Med, 330, 1041, 10.1056/NEJM199404143301503
Horne, 2006, Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database, Am Heart J, 152, 305, 10.1016/j.ahj.2005.12.028
Li, 2000, Family risk score of coronary heart disease (CHD) as a predictor of CHD: the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI family heart study, Genet Epidemiol, 18, 236, 10.1002/(SICI)1098-2272(200003)18:3<236::AID-GEPI4>3.0.CO;2-0
Ciruzzi, 1997, Frequency of family history of acute myocardial infarction in patients with acute myocardial infarction, Am J Cardiol, 80, 122, 10.1016/S0002-9149(97)00304-4
Shiraishi, 2005, Acute myocardial infarction in young Japanese adults, Circ J, 69, 1454, 10.1253/circj.69.1454
Hunt, 1986, A comparison of positive family history definitions for defining risk of future disease, J Chronic Dis, 39, 809, 10.1016/0021-9681(86)90083-4
Williams, 2001, Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study), Am J Cardiol, 87, 129, 10.1016/S0002-9149(00)01303-5
Hawe, 2003, Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study, Ann Hum Genet, 67, 97, 10.1046/j.1469-1809.2003.00017.x
Murabito, 2004, Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study, Ann Intern Med, 140, 434, 10.7326/0003-4819-140-6-200403160-00010
Yoon, 2003, Research priorities for evaluating family history in the prevention of common chronic diseases, Am J Prev Med, 24, 128, 10.1016/S0749-3797(02)00585-8
Magnus, 1983, A comparison of populations self-selected and randomly selected for coronary risk factor screening, Prev Med, 12, 340, 10.1016/0091-7435(83)90243-8
Kip, 2002, Absence of risk factor change in young adults after family heart attack or stroke: the CARDIA Study, Am J Prev Med, 22, 258, 10.1016/S0749-3797(02)00416-6
Becker, 2005, Impact of a community-based multiple risk factor intervention on cardiovascular risk in black families with a history of premature coronary disease, Circulation, 111, 1298, 10.1161/01.CIR.0000157734.97351.B2
Cene, 2008, Sustainability of a multiple risk factor intervention on cardiovascular disease in high-risk African American families, Ethn Dis, 18, 169
Paynter, 2009, Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3, Ann Intern Med, 150, 65, 10.7326/0003-4819-150-2-200901200-00003
Scheuner, 2008, Delivery of genomic medicine for common chronic adult diseases: a systematic review, JAMA, 299, 1320, 10.1001/jama.299.11.1320
Bodmer, 2008, Common and rare variants in multifactorial susceptibility to common diseases, Nat Genet, 40, 695, 10.1038/ng.f.136
McPherson, 2007, A common allele on chromosome 9 associated with coronary heart disease, Science, 316, 1488, 10.1126/science.1142447
Helgadottir, 2007, A common variant on chromosome 9p21 affects the risk of myocardial infarction, Science, 316, 1491, 10.1126/science.1142842
Samani, 2007, Genomewide association analysis of coronary artery disease, N Engl J Med, 357, 443, 10.1056/NEJMoa072366
Assimes, 2008, Susceptibility locus for clinical and subclinical coronary artery disease at chromosome 9p21 in the multi-ethnic ADVANCE study, Hum Mol Genet, 17, 2320, 10.1093/hmg/ddn132
Hinohara, 2008, Replication of the association between a chromosome 9p21 polymorphism and coronary artery disease in Japanese and Korean populations, J Hum Genet, 53, 357, 10.1007/s10038-008-0248-4
Silander, 2009, Worldwide patterns of haplotype diversity at 9p21.3, a locus associated with type 2 diabetes and coronary heart disease, Genome Med, 1, 51, 10.1186/gm51
Gil, 2006, Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all, Nat Rev Mol Cell Biol, 7, 667, 10.1038/nrm1987
Talmud, 2008, Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men, Clin Chem, 54, 467, 10.1373/clinchem.2007.095489
Kathiresan, 2008, Polymorphisms associated with cholesterol and risk of cardiovascular events, N Engl J Med, 358, 1240, 10.1056/NEJMoa0706728
Sanderson, 2007, Genetic testing for heart disease susceptibility: potential impact on motivation to quit smoking, Clin Genet, 71, 501, 10.1111/j.1399-0004.2007.00810.x
Wright, 2007, Is attributing smoking to genetic causes associated with a reduced probability of quit attempt success?, Addiction, 102, 1657, 10.1111/j.1360-0443.2007.01937.x
McBride, 2002, Incorporating genetic susceptibility feedback into a smoking cessation program for African-American smokers with low income, Cancer Epidemiol Biomarkers Prev, 11, 521
Offit, 2008, Genomic profiles for disease risk: predictive or premature?, JAMA, 299, 1353, 10.1001/jama.299.11.1353
Ip, 2009, Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes, Ann Intern Med, 150, 474, 10.7326/0003-4819-150-7-200904070-00007
El Harchaoui, 2007, Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study, J Am Coll Cardiol, 49, 547, 10.1016/j.jacc.2006.09.043
Duprez, 2007, Arterial stiffness as a risk factor for coronary atherosclerosis, Curr Atheroscler Rep, 9, 139, 10.1007/s11883-007-0010-y
Freedman, 2004, Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study, Clin Chem, 50, 1189, 10.1373/clinchem.2004.032763
Ingelsson, 2007, Clinical utility of different lipid measures for prediction of coronary heart disease in men and women, JAMA, 298, 776, 10.1001/jama.298.7.776
Mora, 2009, Advanced lipoprotein testing and subfractionation are not (yet) ready for routine clinical use, Circulation, 119, 2396, 10.1161/CIRCULATIONAHA.108.819359
Erqou, 2009, Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality, JAMA, 302, 412, 10.1001/jama.2009.1063
Dati, 2004, First WHO/IFCC International Reference Reagent for Lipoprotein(a) for Immunoassay—Lp(a) SRM 2B, Clin Chem Lab Med, 42, 670, 10.1515/CCLM.2004.114
Witte, 2004, Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis, J Lipid Res, 45, 1069, 10.1194/jlr.M300395-JLR200
DiAngelantonio, 2009, B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies, Circulation, 120, 2177, 10.1161/CIRCULATIONAHA.109.884866
McKie, 2006, Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure, Hypertension, 47, 874, 10.1161/01.HYP.0000216794.24161.8c
Olsen, 2008, Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex, J Hypertens, 26, 26, 10.1097/HJH.0b013e3282f18301
Wang, 2004, Plasma natriuretic peptide levels and the risk of cardiovascular events and death, N Engl J Med, 350, 655, 10.1056/NEJMoa031994
Kistorp, 2005, N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults, JAMA, 293, 1609, 10.1001/jama.293.13.1609
Daniels, 2008, Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study, J Am Coll Cardiol, 52, 450, 10.1016/j.jacc.2008.04.033
McDonagh, 2001, Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population, Heart, 86, 21, 10.1136/heart.86.1.21
Laukkanen, 2006, Plasma N-terminal fragments of natriuretic propeptides predict the risk of cardiovascular events and mortality in middle-aged men, Eur Heart J, 27, 1230, 10.1093/eurheartj/ehi878
Zethelius, 2008, Use of multiple biomarkers to improve the prediction of death from cardiovascular causes, N Engl J Med, 358, 2107, 10.1056/NEJMoa0707064
Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646
Ridker, 2008, C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men, Circulation, 118, 2243, 10.1161/CIRCULATIONAHA.108.814251
Baigent, 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1
Barzilay, 2006, The association of markers of inflammation with weight change in older adults: the Cardiovascular Health Study, Int J Obes (Lond), 30, 1362, 10.1038/sj.ijo.0803306
Pradhan, 2001, C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus, JAMA, 286, 327, 10.1001/jama.286.3.327
Sesso, 2003, C-reactive protein and the risk of developing hypertension, JAMA, 290, 2945, 10.1001/jama.290.22.2945
Bakhru, 2005, Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey, PLoS Med, 2, e160, 10.1371/journal.pmed.0020160
Balk, 2003, Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review, Ann Intern Med, 139, 670, 10.7326/0003-4819-139-8-200310210-00011
Esposito, 2003, Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial, JAMA, 289, 1799, 10.1001/jama.289.14.1799
Ford, 2002, Does exercise reduce inflammation?, Epidemiology, 13, 561, 10.1097/00001648-200209000-00012
Ridker, 2006, Valsartan, blood pressure reduction, and C-reactive protein: primary report of the Val-MARC trial, Hypertension, 48, 73, 10.1161/01.HYP.0000226046.58883.32
Ockene, 2001, Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults, Clin Chem, 47, 444, 10.1093/clinchem/47.3.444
Koenig, 2003, Refinement of the association of serum C-reactive protein concentration and coronary heart disease risk by correction for within-subject variation over time: the MONICA Augsburg studies, 1984 and 1987, Am J Epidemiol, 158, 357, 10.1093/aje/kwg135
Glynn, 2009, Tracking of high-sensitivity C-reactive protein after an initially elevated concentration: the JUPITER Study, Clin Chem, 55, 305, 10.1373/clinchem.2008.120642
Pearson, 2003, Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association, Circulation, 107, 499, 10.1161/01.CIR.0000052939.59093.45
Danesh, 2004, C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease, N Engl J Med, 350, 1387, 10.1056/NEJMoa032804
Arima, 2008, High-sensitivity C-reactive protein and coronary heart disease in a general population of Japanese: the Hisayama study, Arterioscler Thromb Vasc Biol, 28, 1385, 10.1161/ATVBAHA.107.157164
Best, 2005, C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study, Circulation, 112, 1289, 10.1161/CIRCULATIONAHA.104.489260
Kuller, 1996, Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study: Multiple Risk Factor Intervention Trial, Am J Epidemiol, 144, 537, 10.1093/oxfordjournals.aje.a008963
Albert, 2002, Prospective study of C-reactive protein, homocysteine, and plasma lipid levels as predictors of sudden cardiac death, Circulation, 105, 2595, 10.1161/01.CIR.0000017493.03108.1C
Aviles, 2003, Inflammation as a risk factor for atrial fibrillation, Circulation, 108, 3006, 10.1161/01.CIR.0000103131.70301.4F
Gottdiener, 2000, Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study, J Am Coll Cardiol, 35, 1628, 10.1016/S0735-1097(00)00582-9
Harris, 1999, Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly, Am J Med, 106, 506, 10.1016/S0002-9343(99)00066-2
Pradhan, 2002, Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men, Circulation, 106, 820, 10.1161/01.CIR.0000025636.03561.EE
Casas, 2006, Insight into the nature of the CRP-coronary event association using Mendelian randomization, Int J Epidemiol, 35, 922, 10.1093/ije/dyl041
Casas, 2008, C-reactive protein and coronary heart disease: a critical review, J Intern Med, 264, 295, 10.1111/j.1365-2796.2008.02015.x
Davey, 2003, ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease?, Int J Epidemiol, 32, 1, 10.1093/ije/dyg070
Elliott, 2009, Genetic loci associated with C-reactive protein levels and risk of coronary heart disease, JAMA, 302, 37, 10.1001/jama.2009.954
Pepys, 2008, C-reactive protein is neither a marker nor a mediator of atherosclerosis, Nat Clin Pract Nephrol, 4, 234, 10.1038/ncpneph0778
Cook, 2006, The effect of including C-reactive protein in cardiovascular risk prediction models for women, Ann Intern Med, 145, 21, 10.7326/0003-4819-145-1-200607040-00128
Shah, 2009, Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts, Int J Epidemiol, 38, 217, 10.1093/ije/dyn217
Wilson, 2005, C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study, Arch Intern Med, 165, 2473, 10.1001/archinte.165.21.2473
Ridker, 2003, Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial, Circulation, 108, 2292, 10.1161/01.CIR.0000100688.17280.E6
Ridker, 2007, Baseline characteristics of participants in the JUPITER trial, a randomized placebo-controlled primary prevention trial of statin therapy among individuals with low low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein, Am J Cardiol, 100, 1659, 10.1016/j.amjcard.2007.09.072
Hlatky, 2008, Expanding the orbit of primary prevention--moving beyond JUPITER, N Engl J Med, 359, 2280, 10.1056/NEJMe0808320
Khaw, 2004, Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk, Ann Intern Med, 141, 413, 10.7326/0003-4819-141-6-200409210-00006
Khaw, 2006, Glycated hemoglobin as a marker of cardiovascular risk, Curr Opin Lipidol, 17, 637, 10.1097/MOL.0b013e3280106b95
Knowler, 2002, Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, 346, 393, 10.1056/NEJMoa012512
Lachin, 2007, Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program, Diabetes, 56, 1153, 10.2337/db06-0918
Selvin, 2004, Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus, Ann Intern Med, 141, 421, 10.7326/0003-4819-141-6-200409210-00007
Selvin, 2010, Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults, N Engl J Med, 362, 800, 10.1056/NEJMoa0908359
Pradhan, 2007, Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women, Am J Med, 120, 720, 10.1016/j.amjmed.2007.03.022
Bennett, 2007, HbA(1c) as a screening tool for detection of Type 2 diabetes: a systematic review, Diabet Med, 24, 333, 10.1111/j.1464-5491.2007.02106.x
2010, Standards of medical care in diabetes—2010, Diabetes Care, 33, S11
Pencina, 2008, Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort—invited commentary, Arch Intern Med, 168, 1216, 10.1001/archinte.168.11.1216
Simmons, 2008, Evaluation of the Framingham risk score in the European Prospective Investigation of Cancer-Norfolk cohort: does adding glycated hemoglobin improve the prediction of coronary heart disease events?, Arch Intern Med, 168, 1209, 10.1001/archinte.168.11.1209
Adams, 2009, Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes, Obesity, 17, 559, 10.1038/oby.2008.592
Ibsen, 2005, Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study, Hypertension, 45, 198, 10.1161/01.HYP.0000154082.72286.2a
Ninomiya, 2009, Proteinuria and stroke: a meta-analysis of cohort studies, Am J Kidney Dis, 53, 417, 10.1053/j.ajkd.2008.08.032
Wachtell, 2003, Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study, Ann Intern Med, 139, 901, 10.7326/0003-4819-139-11-200312020-00008
Arnlov, 2005, Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study, Circulation, 112, 969, 10.1161/CIRCULATIONAHA.105.538132
Perkovic, 2008, The relationship between proteinuria and coronary risk: a systematic review and meta-analysis, PLoS Med, 5, e207, 10.1371/journal.pmed.0050207
2009, Standards of medical care in diabetes—2009, Diabetes Care, 32, S13
Aakre, 2008, Postanalytical external quality assessment of urine albumin in primary health care: an international survey, Clin Chem, 54, 1630, 10.1373/clinchem.2007.100917
McQueen, 2008, Requesting and interpreting urine albumin measurements in the primary health care setting, Clin Chem, 54, 1595, 10.1373/clinchem.2008.113431
Lambers Heerspink, 2008, Albuminuria assessed from first-morning-void urine samples versus 24–hour urine collections as a predictor of cardiovascular morbidity and mortality, Am J Epidemiol, 168, 897, 10.1093/aje/kwn209
Levey, 2005, Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO), Kidney Int, 67, 2089, 10.1111/j.1523-1755.2005.00365.x
Bryson, 2006, Racial and ethnic variations in albuminuria in the US Third National Health and Nutrition Examination Survey (NHANES III) population: associations with diabetes and level of CKD, Am J Kidney Dis, 48, 720, 10.1053/j.ajkd.2006.07.023
Coresh, 2007, Prevalence of chronic kidney disease in the United States, JAMA, 298, 2038, 10.1001/jama.298.17.2038
Cirillo, 1998, Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study, Arch Intern Med, 158, 1933, 10.1001/archinte.158.17.1933
Cao, 2008, Cardiovascular and mortality risk prediction and stratification using urinary albumin excretion in older adults ages 68–102: the Cardiovascular Health Study, Atherosclerosis, 197, 806, 10.1016/j.atherosclerosis.2007.07.029
Halimi, 2008, Urinary albumin excretion is a risk factor for diabetes mellitus in men, independently of initial metabolic profile and development of insulin resistance: the DESIR Study, J Hypertens, 26, 2198, 10.1097/HJH.0b013e328310ddff
Wang, 2005, Low-grade albuminuria and the risks of hypertension and blood pressure progression, Circulation, 111, 1370, 10.1161/01.CIR.0000158434.69180.2D
Meigs, 2002, Longitudinal association of glycemia and microalbuminuria: the Framingham Offspring Study, Diabetes Care, 25, 977, 10.2337/diacare.25.6.977
Papaioannou, 2004, Brachial artery reactivity in asymptomatic patients with type 2 diabetes mellitus and microalbuminuria (from the Detection of Ischemia in Asymptomatic Diabetics-brachial artery reactivity study), Am J Cardiol, 94, 294, 10.1016/j.amjcard.2004.04.022
Malik, 2007, Urinary albumin excretion is associated with impaired flow- and nitroglycerin-mediated brachial artery dilatation in hypertensive adults, J Hum Hypertens, 21, 231, 10.1038/sj.jhh.1002143
Kshirsagar, 2008, Association of C-reactive protein and microalbuminuria (from the National Health and Nutrition Examination Surveys, 1999 to 2004), Am J Cardiol, 101, 401, 10.1016/j.amjcard.2007.08.041
DeZeeuw, 2006, Microalbuminuria as an early marker for cardiovascular disease, J Am Soc Nephrol, 17, 2100, 10.1681/ASN.2006050517
Astor, 2008, Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population, Am J Epidemiol, 167, 1226, 10.1093/aje/kwn033
Hallan, 2007, Association of kidney function and albuminuria with cardiovascular mortality in older vs younger individuals: The HUNT II Study, Arch Intern Med, 167, 2490, 10.1001/archinte.167.22.2490
Tillin, 2005, Microalbuminuria and coronary heart disease risk in an ethnically diverse UK population: a prospective cohort study, J Am Soc Nephrol, 16, 3702, 10.1681/ASN.2005060584
Xu, 2007, Albuminuria within the “normal” range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study, Am J Kidney Dis, 49, 208, 10.1053/j.ajkd.2006.10.017
Wang, 2006, Multiple biomarkers for the prediction of first major cardiovascular events and death, N Engl J Med, 355, 2631, 10.1056/NEJMoa055373
Ballantyne, 2007, Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases, Eur J Cardiovasc Prev Rehabil, 14, 3, 10.1097/01.hjr.0000239464.18509.f1
Daniels, 2008, Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study, J Am Coll Cardiol, 51, 913, 10.1016/j.jacc.2007.10.048
Garza, 2007, Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review, Mayo Clin Proc, 82, 159, 10.1016/S0025-6196(11)60992-0
Koenig, 2004, Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14–year follow-up of a large cohort from southern Germany, Circulation, 110, 1903, 10.1161/01.CIR.0000143377.53389.C8
Zalewski, 2005, Role of lipoprotein-associated phospholipase A2 in atherosclerosis: biology, epidemiology, and possible therapeutic target, Arterioscler Thromb Vasc Biol, 25, 923, 10.1161/01.ATV.0000160551.21962.a7
Persson, 2007, The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort, Atherosclerosis, 190, 388, 10.1016/j.atherosclerosis.2006.02.016
Brilakis, 2008, Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study, Atherosclerosis, 199, 110, 10.1016/j.atherosclerosis.2007.10.010
Folsom, 2006, An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study, Arch Intern Med, 166, 1368, 10.1001/archinte.166.13.1368
Tsimikas, 2009, Lipoprotein-associated phospholipase A2 activity, ferritin levels, metabolic syndrome, and 10–year cardiovascular and non-cardiovascular mortality: results from the Bruneck study, Eur Heart J, 30, 107, 10.1093/eurheartj/ehn502
Packard, 2000, Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease, N Engl J Med, 343, 1148, 10.1056/NEJM200010193431603
Khuseyinova, 2007, Predicting the risk of cardiovascular disease: where does lipoprotein-associated phospholipase A(2) fit in?, Mol Diagn Ther, 11, 203, 10.1007/BF03256242
DeBacquer, 2002, Electrocardiographic findings and global coronary risk assessment, Eur Heart J, 23, 268, 10.1053/euhj.2001.2849
Okin, 2004, Combined echocardiographic left ventricular hypertrophy and electrocardiographic ST depression improve prediction of mortality in American Indians: the Strong Heart Study, Hypertension, 43, 769, 10.1161/01.HYP.0000118585.73688.c6
Ashley, 2001, An evidence-based review of the resting electrocardiogram as a screening technique for heart disease, Prog Cardiovasc Dis, 44, 55, 10.1053/pcad.2001.24683
Schlant, 1992, Guidelines for electrocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Electrocardiography), J Am Coll Cardiol, 19, 473, 10.1016/S0735-1097(10)80258-X
2004, Screening for coronary heart disease: recommendation statement, Ann Intern Med, 140, 569, 10.7326/0003-4819-140-7-200404060-00001
DeBacquer, 1998, Prognostic value of ECG findings for total, cardiovascular disease, and coronary heart disease death in men and women, Heart, 80, 570, 10.1136/hrt.80.6.570
Kumar, 2008, Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study, Circulation, 118, 2790, 10.1161/CIRCULATIONAHA.108.772541
Daviglus, 1999, Association of nonspecific minor ST-T abnormalities with cardiovascular mortality: the Chicago Western Electric Study, JAMA, 281, 530, 10.1001/jama.281.6.530
Desai, 2006, Prognostic significance of quantitative QRS duration, Am J Med, 119, 600, 10.1016/j.amjmed.2005.08.028
Kannel, 1970, Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease, Ann Intern Med, 72, 813, 10.7326/0003-4819-72-6-813
Larsen, 2002, Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave: the Copenhagen City Heart Study, Eur Heart J, 23, 315, 10.1053/euhj.2001.2774
Sigurdsson, 1995, Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris: the Reykjavik Study, Ann Intern Med, 122, 96, 10.7326/0003-4819-122-2-199501150-00003
Gorodeski, 2009, Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms, Am Heart J, 158, 61, 10.1016/j.ahj.2009.04.015
Okin, 2001, Computerized ST depression analysis improves prediction of all-cause and cardiovascular mortality: the Strong Heart Study, Ann Noninvasive Electrocardiol, 6, 107, 10.1111/j.1542-474X.2001.tb00094.x
Myerburg, 2007, Electrocardiograms should be included in preparticipation screening of athletes, Circulation, 116, 2616, 10.1161/CIRCULATIONAHA.107.733519
Denes, 2007, Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality, JAMA, 297, 978, 10.1001/jama.297.9.978
Kannel, 1984, Incidence and prognosis of unrecognized myocardial infarction: an update on the Framingham Study, N Engl J Med, 311, 1144, 10.1056/NEJM198411013111802
Okin, 2004, Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients, Hypertension, 44, 48, 10.1161/01.HYP.0000132556.91792.6a
Okin, 2004, Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events, JAMA, 292, 2343, 10.1001/jama.292.19.2343
Wachtell, 2007, Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study, Circulation, 116, 700, 10.1161/CIRCULATIONAHA.106.666594
Okin, 2006, Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study, Circulation, 113, 67, 10.1161/CIRCULATIONAHA.105.569491
Gardin, 2004, Left ventricular hypertrophy: the next treatable, silent killer?, JAMA, 292, 2396, 10.1001/jama.292.19.2396
Corrado, 2006, Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program, JAMA, 296, 1593, 10.1001/jama.296.13.1593
Verdecchia, 2001, Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study, J Am Coll Cardiol, 38, 1829, 10.1016/S0735-1097(01)01663-1
Rodriguez, 2006, Prognostic implications of left ventricular mass among Hispanics: the Northern Manhattan Study, Hypertension, 48, 87, 10.1161/01.HYP.0000223330.03088.58
Beache, 2001, Attenuated myocardial vasodilator response in patients with hypertensive hypertrophy revealed by oxygenation-dependent magnetic resonance imaging, Circulation, 104, 1214, 10.1161/hc3601.096307
Nunez, 2004, Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women, Am J Cardiol, 94, 1383, 10.1016/j.amjcard.2004.08.012
Cuspidi, 2008, Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?, Am J Hypertens, 21, 458, 10.1038/ajh.2007.85
Lang, 2005, Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, J Am Soc Echocardiogr, 18, 1440, 10.1016/j.echo.2005.10.005
Basavarajaiah, 2008, Ethnic differences in left ventricular remodeling in highly-trained athletes relevance to differentiating physiologic left ventricular hypertrophy from hypertrophic cardiomyopathy, J Am Coll Cardiol, 51, 2256, 10.1016/j.jacc.2007.12.061
Levy, 1990, Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study, N Engl J Med, 322, 1561, 10.1056/NEJM199005313222203
Chobanian, 2003, The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report, JAMA, 289, 2560, 10.1001/jama.289.19.2560
Schmieder, 1996, Reversal of left ventricular hypertrophy in essential hypertension: a meta-analysis of randomized double-blind studies, JAMA, 275, 1507, 10.1001/jama.1996.03530430051039
Liebson, 1995, Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS), Circulation, 91, 698, 10.1161/01.CIR.91.3.698
Gottdiener, 1997, Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: comparison of six antihypertensive agents, Circulation, 95, 2007, 10.1161/01.CIR.95.8.2007
Mathew, 2001, Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril, Circulation, 104, 1615, 10.1161/hc3901.096700
Devereux, 2004, Prognostic significance of left ventricular mass change during treatment of hypertension, JAMA, 292, 2350, 10.1001/jama.292.19.2350
Nambi, 2010, Carotid intima-media thickness and the presence or absence of plaque improves prediction of coronary heart disease risk in the Atherosclerosis Risk in Communities (ARIC) study, J Am Coll Cardiol, 55, 1600, 10.1016/j.jacc.2009.11.075
Stein, 2008, Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force, J Am Soc Echocardiogr, 21, 93, 10.1016/j.echo.2007.11.011
Touboul, 2005, Design, baseline characteristics and carotid intima-media thickness reproducibility in the PARC study, Cerebrovasc Dis, 19, 57, 10.1159/000081913
Peretz, 2007, Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization, BMC Cardiovasc Disord, 7, 11, 10.1186/1471-2261-7-11
Lorenz, 2007, Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis, Circulation, 115, 459, 10.1161/CIRCULATIONAHA.106.628875
Belcaro, 2001, Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10–year follow-up study (the CAFES-CAVE study(1)), Atherosclerosis, 156, 379, 10.1016/S0021-9150(00)00665-1
Salonen JT, Salonen R. Ultrasound B-mode in observational studies of atherosclerotic progression. Circ J. 1993;87:II56–II65.
Chambless, 1997, Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987–1993, Am J Epidemiol, 146, 483, 10.1093/oxfordjournals.aje.a009302
Bots, 1997, Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study, Circulation, 96, 1432, 10.1161/01.CIR.96.5.1432
O'Leary, 1999, Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults, N Engl J Med, 340, 14, 10.1056/NEJM199901073400103
Folsom, 2003, Prediction of coronary heart disease in middle-aged adults with diabetes, Diabetes Care, 26, 2777, 10.2337/diacare.26.10.2777
Kuller, 2000, Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality, Arterioscler Thromb Vasc Biol, 20, 823, 10.1161/01.ATV.20.3.823
Folsom, 2008, Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA), Arch Intern Med, 168, 1333, 10.1001/archinte.168.12.1333
Newman, 2008, Coronary artery calcium, carotid artery wall thickness, and cardiovascular disease outcomes in adults 70 to 99 years old, Am J Cardiol, 101, 186, 10.1016/j.amjcard.2007.07.075
Hodis, 1998, The role of carotid arterial intima-media thickness in predicting clinical coronary events, Ann Intern Med, 128, 262, 10.7326/0003-4819-128-4-199802150-00002
Bovet, 2002, Improved smoking cessation in smokers given ultrasound photographs of their own atherosclerotic plaques, Prev Med, 34, 215, 10.1006/pmed.2001.0976
Kuvin, 2007, Assessment of peripheral vascular endothelial function in the ambulatory setting, Vasc Med, 12, 13, 10.1177/1358863X06076227
Takase, 1998, Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease, Am J Cardiol, 82, 1535, 10.1016/S0002-9149(98)00702-4
Bots, 2005, Assessment of flow-mediated vasodilatation (FMD) of the brachial artery: effects of technical aspects of the FMD measurement on the FMD response, Eur Heart J, 26, 363, 10.1093/eurheartj/ehi017
Kuvin, 2003, Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitude, Am Heart J, 146, 168, 10.1016/S0002-8703(03)00094-2
Witte, 2005, Is the association between flow-mediated dilation and cardiovascular risk limited to low-risk populations?, J Am Coll Cardiol, 45, 1987, 10.1016/j.jacc.2005.02.073
Hamburg, 2008, Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study, Circulation, 117, 2467, 10.1161/CIRCULATIONAHA.107.748574
Yeboah, 2007, Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study, Circulation, 115, 2390, 10.1161/CIRCULATIONAHA.106.678276
Suzuki, 2008, Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS), Am Heart J, 156, 405, 10.1016/j.ahj.2008.02.022
Rossi, 2008, Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women, J Am Coll Cardiol, 51, 997, 10.1016/j.jacc.2007.11.044
Modena, 2002, Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women, J Am Coll Cardiol, 40, 505, 10.1016/S0735-1097(02)01976-9
Kullo, 2007, Arterial ultrasonography and tonometry as adjuncts to cardiovascular risk stratification, J Am Coll Cardiol, 49, 1413, 10.1016/j.jacc.2006.11.039
Laurent, 2006, Expert consensus document on arterial stiffness: methodological issues and clinical applications, Eur Heart J, 27, 2588, 10.1093/eurheartj/ehl254
Meaume, 2001, Aortic pulse wave velocity predicts cardiovascular mortality in subjects >70 years of age, Arterioscler Thromb Vasc Biol, 21, 2046, 10.1161/hq1201.100226
Stork, 2004, Carotid artery plaque burden, stiffness, and mortality risk in elderly men: a prospective, population-based cohort study, Circulation, 110, 344, 10.1161/01.CIR.0000134966.10793.C9
Sutton-Tyrrell, 2005, Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults, Circulation, 111, 3384, 10.1161/CIRCULATIONAHA.104.483628
Shokawa, 2005, Pulse wave velocity predicts cardiovascular mortality: findings from the Hawaii-Los Angeles-Hiroshima study, Circ J, 69, 259, 10.1253/circj.69.259
Dolan, 2006, Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study, Hypertension, 47, 365, 10.1161/01.HYP.0000200699.74641.c5
Willum-Hansen, 2006, Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population, Circulation, 113, 664, 10.1161/CIRCULATIONAHA.105.579342
Hansen, 2006, Ambulatory arterial stiffness index predicts stroke in a general population, J Hypertens, 24, 2247, 10.1097/01.hjh.0000249703.57478.78
Mattace-Raso, 2006, Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study, Circulation, 113, 657, 10.1161/CIRCULATIONAHA.105.555235
Roman, 2007, Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study, Hypertension, 50, 197, 10.1161/HYPERTENSIONAHA.107.089078
Leone, 2008, Distension of the carotid artery and risk of coronary events: the three-city study, Arterioscler Thromb Vasc Biol, 28, 1392, 10.1161/ATVBAHA.108.164582
Pini, 2008, Central but not brachial blood pressure predicts cardiovascular events in an unselected geriatric population: the ICARe Dicomano Study, J Am Coll Cardiol, 51, 2432, 10.1016/j.jacc.2008.03.031
Fowkes, 2008, Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis, JAMA, 300, 197, 10.1001/jama.300.2.197
Ostchega, 2007, Prevalence of peripheral arterial disease and risk factors in persons aged 60 and older: data from the National Health and Nutrition Examination Survey 1999–2004, J Am Geriatr Soc, 55, 583, 10.1111/j.1532-5415.2007.01123.x
Resnick, 2005, Prevalence of elevated ankle-brachial index in the United States 1999 to 2002, Am J Med, 118, 676, 10.1016/j.amjmed.2004.11.025
Allison, 2008, A high ankle-brachial index is associated with increased cardiovascular disease morbidity and lower quality of life, J Am Coll Cardiol, 51, 1292, 10.1016/j.jacc.2007.11.064
Criqui, 1992, Mortality over a period of 10 years in patients with peripheral arterial disease, N Engl J Med, 326, 381, 10.1056/NEJM199202063260605
Hooi, 2004, Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7–year follow-up study, J Clin Epidemiol, 57, 294, 10.1016/j.jclinepi.2003.09.003
Kornitzer, 1995, Ankle/arm pressure index in asymptomatic middle-aged males: an independent predictor of ten-year coronary heart disease mortality, Angiology, 46, 211, 10.1177/000331979504600304
Kuller, 1995, Subclinical disease as an independent risk factor for cardiovascular disease, Circulation, 92, 720, 10.1161/01.CIR.92.4.720
Leng, 1996, Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study, BMJ, 313, 1440, 10.1136/bmj.313.7070.1440
McDermott, 2005, Ankle-brachial index and subclinical cardiac and carotid disease: the multi-ethnic study of atherosclerosis, Am J Epidemiol, 162, 33, 10.1093/aje/kwi167
Murabito, 2003, The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study, Arch Intern Med, 163, 1939, 10.1001/archinte.163.16.1939
Newman, 1999, Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study, Arterioscler Thromb Vasc Biol, 19, 538, 10.1161/01.ATV.19.3.538
O'Hare, 2006, Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study, Circulation, 113, 388, 10.1161/CIRCULATIONAHA.105.570903
van der Meer, 2004, Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study, Circulation, 109, 1089, 10.1161/01.CIR.0000120708.59903.1B
Weatherley, 2007, The association of the ankle-brachial index with incident coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study, 1987–2001, BMC Cardiovasc Disord, 7, 3, 10.1186/1471-2261-7-3
Resnick, 2004, Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study, Circulation, 109, 733, 10.1161/01.CIR.0000112642.63927.54
Abbott, 2000, Ankle/brachial blood pressure in men >70 years of age and the risk of coronary heart disease, Am J Cardiol, 86, 280, 10.1016/S0002-9149(00)00914-0
Gulati, 2003, Exercise capacity and the risk of death in women: the St James Women Take Heart Project, Circulation, 108, 1554, 10.1161/01.CIR.0000091080.57509.E9
Adabag, 2008, Relation of heart rate parameters during exercise test to sudden death and all-cause mortality in asymptomatic men, Am J Cardiol, 101, 1437, 10.1016/j.amjcard.2008.01.021
Wei, 1999, Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men, JAMA, 282, 1547, 10.1001/jama.282.16.1547
Lauer, 2005, Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention, Circulation, 112, 771, 10.1161/CIRCULATIONAHA.105.166543
Gianrossi, 1989, Exercise-induced ST depression in the diagnosis of coronary artery disease, Circulation, 80, 87, 10.1161/01.CIR.80.1.87
Goraya, 2000, Prognostic value of treadmill exercise testing in elderly persons, Ann Intern Med, 132, 862, 10.7326/0003-4819-132-11-200006060-00003
Gibbons, 2002, ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines), J Am Coll Cardiol, 40, 1530, 10.1016/S0735-1097(02)02164-2
Mark, 2003, Exercise capacity: the prognostic variable that doesn't get enough respect, Circulation, 108, 1534, 10.1161/01.CIR.0000094408.38603.7E
Myers, 2002, Exercise capacity and mortality among men referred for exercise testing, N Engl J Med, 346, 793, 10.1056/NEJMoa011858
Kodama, 2009, Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis, JAMA, 301, 2024, 10.1001/jama.2009.681
Lauer, 2007, An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram, Ann Intern Med, 147, 821, 10.7326/0003-4819-147-12-200712180-00001
Aktas, 2004, Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program, JAMA, 292, 1462, 10.1001/jama.292.12.1462
Cole, 1999, Heart-rate recovery immediately after exercise as a predictor of mortality, N Engl J Med, 341, 1351, 10.1056/NEJM199910283411804
Frolkis, 2003, Frequent ventricular ectopy after exercise as a predictor of death, N Engl J Med, 348, 781, 10.1056/NEJMoa022353
Jouven, 2005, Heart-rate profile during exercise as a predictor of sudden death, N Engl J Med, 352, 1951, 10.1056/NEJMoa043012
Jouven, 2003, Ventricular ectopy after exercise as a predictor of death, N Engl J Med, 348, 2357, 10.1056/NEJMc030797
Lauer, 1999, Impaired chronotropic response to exercise stress testing as a predictor of mortality, JAMA, 281, 524, 10.1001/jama.281.6.524
Nishime, 2000, Heart rate recovery and treadmill exercise score as predictors of mortality in patients referred for exercise ECG, JAMA, 284, 1392, 10.1001/jama.284.11.1392
Khan, 2005, Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol), Am J Cardiol, 96, 1328, 10.1016/j.amjcard.2005.06.082
Lauer, 1996, Impaired heart rate response to graded exercise: prognostic implications of chronotropic incompetence in the Framingham Heart Study, Circulation, 93, 1520, 10.1161/01.CIR.93.8.1520
Imai, 1994, Vagally mediated heart rate recovery after exercise is accelerated in athletes but blunted in patients with chronic heart failure, J Am Coll Cardiol, 24, 1529, 10.1016/0735-1097(94)90150-3
Cole, 2000, Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort, Ann Intern Med, 132, 552, 10.7326/0003-4819-132-7-200004040-00007
Mora, 2003, Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20–year follow-up of the lipid research clinics prevalence study, JAMA, 290, 1600, 10.1001/jama.290.12.1600
Shetler, 2001, Heart rate recovery: validation and methodologic issues, J Am Coll Cardiol, 38, 1980, 10.1016/S0735-1097(01)01652-7
Mark, 1991, Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease, N Engl J Med, 325, 849, 10.1056/NEJM199109193251204
Kwok, 1999, Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG, JAMA, 282, 1047, 10.1001/jama.282.11.1047
Marwick, 2003, Prediction of mortality in patients without angina: use of an exercise score and exercise echocardiography, Eur Heart J, 24, 1223, 10.1016/S0195-668X(03)00192-1
Faglia, 2005, Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular risk: an open-label randomized pilot study, Am Heart J, 149, e1, 10.1016/j.ahj.2004.07.027
Einstein, 2007, Radiation dose to patients from cardiac diagnostic imaging, Circulation, 116, 1290, 10.1161/CIRCULATIONAHA.107.688101
Berman, 2009, Screening for coronary artery disease in diabetic patients: a commentary, J Nucl Cardiol, 16, 851, 10.1007/s12350-009-9129-2
Zellweger, 2009, Threshold, incidence, and predictors of prognostically high-risk silent ischemia in asymptomatic patients without prior diagnosis of coronary artery disease, J Nucl Cardiol, 16, 193, 10.1007/s12350-008-9016-2
Khandaker, 2009, Stress single photon emission computed tomography for detection of coronary artery disease and risk stratification of asymptomatic patients at moderate risk, J Nucl Cardiol, 16, 516, 10.1007/s12350-009-9085-x
Bax, 2006, The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes, J Am Coll Cardiol, 48, 754, 10.1016/j.jacc.2006.04.077
Lacourciere, 2006, Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging, Can J Cardiol, 22, 16A
Nakajima, 2009, Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1–year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging, Eur J Nucl Med Mol Imaging, 36, 2049, 10.1007/s00259-009-1207-9
Scholte, 2009, Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus, Eur J Nucl Med Mol Imaging, 36, 567, 10.1007/s00259-008-0967-y
Valensi, 2005, Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study, Diabetes Care, 28, 2722, 10.2337/diacare.28.11.2722
Wackers, 2007, Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study, Diabetes Care, 30, 2892, 10.2337/dc07-1250
Young, 2009, Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial, JAMA, 301, 1547, 10.1001/jama.2009.476
Ahmadi, 2009, Vascular dysfunction measured by fingertip thermal monitoring is associated with the extent of myocardial perfusion defect, J Nucl Cardiol, 16, 431, 10.1007/s12350-008-9044-y
Berman, 2004, Relationship between stress-induced myocardial ischemia and atherosclerosis measured by coronary calcium tomography, J Am Coll Cardiol, 44, 923, 10.1016/j.jacc.2004.06.042
Blumenthal, 2006, Comparison of coronary calcium and stress myocardial perfusion imaging in apparently healthy siblings of individuals with premature coronary artery disease, Am J Cardiol, 97, 328, 10.1016/j.amjcard.2005.08.048
Rozanski, 2007, Clinical outcomes after both coronary calcium scanning and exercise myocardial perfusion scintigraphy, J Am Coll Cardiol, 49, 1352, 10.1016/j.jacc.2006.12.035
Rozanski, 2007, Use of coronary calcium scanning for predicting inducible myocardial ischemia: influence of patients' clinical presentation, J Nucl Cardiol, 14, 669, 10.1016/j.nuclcard.2007.07.005
Schenker, 2008, Interrelation of coronary calcification, myocardial ischemia, and outcomes in patients with intermediate likelihood of coronary artery disease: a combined positron emission tomography/computed tomography study, Circulation, 117, 1693, 10.1161/CIRCULATIONAHA.107.717512
Anand, 2006, Risk stratification in uncomplicated type 2 diabetes: prospective evaluation of the combined use of coronary artery calcium imaging and selective myocardial perfusion scintigraphy, Eur Heart J, 27, 713, 10.1093/eurheartj/ehi808
Miller, 2004, Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes, Am Heart J, 147, 890, 10.1016/j.ahj.2003.08.015
Rajagopalan, 2005, Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging, J Am Coll Cardiol, 45, 43, 10.1016/j.jacc.2004.06.078
Sorajja, 2005, Improved survival in asymptomatic diabetic patients with high-risk SPECT imaging treated with coronary artery bypass grafting, Circulation, 112, I311, 10.1161/CIRCULATIONAHA.104.525022
Greenland, 2004, Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals, JAMA, 291, 210, 10.1001/jama.291.2.210
Lakoski, 2007, Coronary artery calcium scores and risk for cardiovascular events in women classified as “low risk” based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA), Arch Intern Med, 167, 2437, 10.1001/archinte.167.22.2437
Taylor, 2005, Coronary calcium independently predicts incident premature coronary heart disease over measured cardiovascular risk factors: mean three-year outcomes in the Prospective Army Coronary Calcium (PACC) project, J Am Coll Cardiol, 46, 807, 10.1016/j.jacc.2005.05.049
Budoff, 2009, Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis), J Am Coll Cardiol, 53, 345, 10.1016/j.jacc.2008.07.072
Nasir, 2003, Electron beam CT versus helical CT scans for assessing coronary calcification: current utility and future directions, Am Heart J, 146, 969, 10.1016/S0002-8703(03)00450-2
Greenland, 2005, Coronary computed tomography in coronary risk assessment, J Cardiopulm Rehabil, 25, 3, 10.1097/00008483-200501000-00002
Schauer, 2009, NCRP Report No. 160, Ionizing Radiation Exposure of the Population of the United States, medical exposure—are we doing less with more, and is there a role for health physicists?, Health Phys, 97, 1, 10.1097/01.HP.0000356672.44380.b7
Parker, 2005, Female breast radiation exposure during CT pulmonary angiography, AJR Am J Roentgenol, 185, 1228, 10.2214/AJR.04.0770
Morin, 2003, Radiation dose in computed tomography of the heart, Circulation, 107, 917, 10.1161/01.CIR.0000048965.56529.C2
Kim, 2009, Coronary artery calcification screening: estimated radiation dose and cancer risk, Arch Intern Med, 169, 1188, 10.1001/archinternmed.2009.162
Kalia, 2006, Visualizing coronary calcium is associated with improvements in adherence to statin therapy, Atherosclerosis, 185, 394, 10.1016/j.atherosclerosis.2005.06.018
Orakzai, 2008, Effect of patient visualization of coronary calcium by electron beam computed tomography on changes in beneficial lifestyle behaviors, Am J Cardiol, 101, 999, 10.1016/j.amjcard.2007.11.059
O'Malley, 2003, Impact of electron beam tomography, with or without case management, on motivation, behavioral change, and cardiovascular risk profile: a randomized controlled trial, JAMA, 289, 2215, 10.1001/jama.289.17.2215
Raggi, 2004, Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy, Arterioscler Thromb Vasc Biol, 24, 1272, 10.1161/01.ATV.0000127024.40516.ef
Taylor, 2008, Community-based provision of statin and aspirin after the detection of coronary artery calcium within a community-based screening cohort, J Am Coll Cardiol, 51, 1337, 10.1016/j.jacc.2007.11.069
Nasir, 2010, Coronary artery calcium in relation to initiation and continuation of cardiovascular preventative medications: the Multiethnic Study of Atherosclerosis (MESA), Circ Qual Care Outcomes, 3, 228, 10.1161/CIRCOUTCOMES.109.893396
Michos, 2006, Framingham risk equation underestimates subclinical atherosclerosis risk in asymptomatic women, Atherosclerosis, 184, 201, 10.1016/j.atherosclerosis.2005.04.004
Raggi, 2008, Coronary artery calcium to predict all-cause mortality in elderly men and women, J Am Coll Cardiol, 52, 17, 10.1016/j.jacc.2008.04.004
Raggi, 2004, Gender-based differences in the prognostic value of coronary calcification, J Womens Health (Larchmt), 13, 273, 10.1089/154099904323016437
Vliegenthart, 2005, Coronary calcification improves cardiovascular risk prediction in the elderly, Circulation, 112, 572, 10.1161/CIRCULATIONAHA.104.488916
Arad, 2005, Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial, J Am Coll Cardiol, 46, 166, 10.1016/j.jacc.2005.02.089
Park, 2002, Combined use of computed tomography coronary calcium scores and C-reactive protein levels in predicting cardiovascular events in nondiabetic individuals, Circulation, 106, 2073, 10.1161/01.CIR.0000033819.29662.09
Choi, 2008, Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals, J Am Coll Cardiol, 52, 357, 10.1016/j.jacc.2008.02.086
Hausleiter, 2009, Estimated radiation dose associated with cardiac CT angiography, JAMA, 301, 500, 10.1001/jama.2009.54
Choudhury, 2002, MRI and characterization of atherosclerotic plaque: emerging applications and molecular imaging, Arterioscler Thromb Vasc Biol, 22, 1065, 10.1161/01.ATV.0000019735.54479.2F
Fayad, 2001, Clinical imaging of the high-risk or vulnerable atherosclerotic plaque, Circ Res, 89, 305, 10.1161/hh1601.095596
Saam, 2005, Quantitative evaluation of carotid plaque composition by in vivo MRI, Arterioscler Thromb Vasc Biol, 25, 234, 10.1161/01.ATV.0000149867.61851.31
Trivedi, 2004, Multi-sequence in vivo MRI can quantify fibrous cap and lipid core components in human carotid atherosclerotic plaques, Eur J Vasc Endovasc Surg, 28, 207, 10.1016/j.ejvs.2004.05.001
Kampschulte, 2004, Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging, Circulation, 110, 3239, 10.1161/01.CIR.0000147287.23741.9A
Moody, 2003, Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia, Circulation, 107, 3047, 10.1161/01.CIR.0000074222.61572.44
Lindsay, 2008, Form to function: current and future roles for atherosclerosis imaging in drug development, Nat Rev Drug Discov, 7, 517, 10.1038/nrd2588
Cai, 2005, In vivo quantitative measurement of intact fibrous cap and lipid-rich necrotic core size in atherosclerotic carotid plaque: comparison of high-resolution, contrast-enhanced magnetic resonance imaging and histology, Circulation, 112, 3437, 10.1161/CIRCULATIONAHA.104.528174
Wasserman, 2002, Carotid artery atherosclerosis: in vivo morphologic characterization with gadolinium-enhanced double-oblique MR imaging initial results, Radiology, 223, 566, 10.1148/radiol.2232010659
Jaffer, 2002, In vivo imaging of thrombin activity in experimental thrombi with thrombin-sensitive near-infrared molecular probe, Arterioscler Thromb Vasc Biol, 22, 1929, 10.1161/01.ATV.0000033089.56970.2D
Li, 2004, Using MRI to assess aortic wall thickness in the Multiethnic Study of Atherosclerosis: distribution by race, sex, and age, Am J Roentgenol, 182, 593, 10.2214/ajr.182.3.1820593
Wasserman, 2008, Risk factor associations with the presence of a lipid core in carotid plaque of asymptomatic individuals using high-resolution MRI: the Multi-Ethnic Study of Atherosclerosis (MESA), Stroke, 39, 329, 10.1161/STROKEAHA.107.498634
Yuan, 2002, Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke, Circulation, 105, 181, 10.1161/hc0202.102121
Ouhlous, 2005, Carotid plaque composition and cerebral infarction: MR imaging study, AJNR Am J Neuroradiol, 26, 1044
Lin, 2006, Carotid vulnerable lesions are related to accelerated recurrence for cerebral infarction magnetic resonance imaging study, Acad Radiol, 13, 1180, 10.1016/j.acra.2006.07.004
Takaya, 2005, Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study, Circulation, 111, 2768, 10.1161/CIRCULATIONAHA.104.504167
Takaya, 2006, Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI—initial results, Stroke, 37, 818, 10.1161/01.STR.0000204638.91099.91
Tang, 2009, The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study: evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease, J Am Coll Cardiol, 53, 2039, 10.1016/j.jacc.2009.03.018
Rudd, 2008, Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations, J Nucl Med, 49, 871, 10.2967/jnumed.107.050294
Sanz, 2008, Imaging of atherosclerotic cardiovascular disease, Nature, 451, 953, 10.1038/nature06803
Silvera, 2009, Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries, Atherosclerosis, 207, 139, 10.1016/j.atherosclerosis.2009.04.023
Becker, 2008, Predictive value of coronary calcifications for future cardiac events in asymptomatic patients with diabetes mellitus: a prospective study in 716 patients over 8 years, BMC Cardiovasc Disord, 8, 27, 10.1186/1471-2261-8-27
Elkeles, 2008, Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study, Eur Heart J, 29, 2244, 10.1093/eurheartj/ehn279
Scholte, 2008, Prevalence of coronary artery disease and plaque morphology assessed by multi-slice computed tomography coronary angiography and calcium scoring in asymptomatic patients with type 2 diabetes, Heart, 94, 290, 10.1136/hrt.2007.121921
Becker, 2008, Predictive value of coronary calcifications for future cardiac events in asymptomatic individuals, Am Heart J, 155, 154, 10.1016/j.ahj.2007.08.024
2008, Standards of medical care in diabetes—2008, Diabetes Care, 31, S12
Kannel, 1979, Diabetes and cardiovascular disease: the Framingham Study, JAMA, 241, 2035, 10.1001/jama.1979.03290450033020
Haffner, 1998, Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction, N Engl J Med, 339, 229, 10.1056/NEJM199807233390404
Grundy, 2002, Prevention Conference VI: diabetes and cardiovascular disease: Executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association, Circulation, 105, 2231, 10.1161/01.CIR.0000013952.86046.DD
Scholte, 2006, Screening of asymptomatic patients with type 2 diabetes mellitus for silent coronary artery disease: combined use of stress myocardial perfusion imaging and coronary calcium scoring, J Nucl Cardiol, 13, 11, 10.1016/j.nuclcard.2005.11.002
Pundziute, 2009, Type 2 diabetes is associated with more advanced coronary atherosclerosis on multislice computed tomography and virtual histology intravascular ultrasound, J Nucl Cardiol, 16, 376, 10.1007/s12350-008-9046-9
Raggi, 2004, Prognostic value of coronary artery calcium screening in subjects with and without diabetes, J Am Coll Cardiol, 43, 1663, 10.1016/j.jacc.2003.09.068
Hoff, 2003, The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease, J Am Coll Cardiol, 41, 1008, 10.1016/S0735-1097(02)02975-3
Schurgin, 2001, Increased prevalence of significant coronary artery calcification in patients with diabetes, Diabetes Care, 24, 335, 10.2337/diacare.24.2.335
Qu, 2003, Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects, Diabetes Care, 26, 905, 10.2337/diacare.26.3.905
Lee, 2001, Clinical utility of the exercise ECG in patients with diabetes and chest pain, Chest, 119, 1576, 10.1378/chest.119.5.1576
Janand-Delenne, 1999, Silent myocardial ischemia in patients with diabetes: who to screen, Diabetes Care, 22, 1396, 10.2337/diacare.22.9.1396
Koistinen, 1990, Evaluation of exercise electrocardiography and thallium tomographic imaging in detecting asymptomatic coronary artery disease in diabetic patients, Br Heart J, 63, 7, 10.1136/hrt.63.1.7
Bacci, 2002, Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test, Eur J Endocrinol, 147, 649, 10.1530/eje.0.1470649
Rubler, 1987, Predictive value of clinical and exercise variables for detection of coronary artery disease in men with diabetes mellitus, Am J Cardiol, 59, 1310, 10.1016/0002-9149(87)90910-6
Fornengo, 2006, Prevalence of silent myocardial ischaemia in new-onset middle-aged type 2 diabetic patients without other cardiovascular risk factors, Diabet Med, 23, 775, 10.1111/j.1464-5491.2006.01910.x
Sozzi, 2007, Prognostic significance of myocardial ischemia during dobutamine stress echocardiography in asymptomatic patients with diabetes mellitus and no prior history of coronary events, Am J Cardiol, 99, 1193, 10.1016/j.amjcard.2006.12.027
Wackers, 2004, Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study, Diabetes Care, 27, 1954, 10.2337/diacare.27.8.1954
Zellweger, 2004, Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients, Eur Heart J, 25, 543, 10.1016/j.ehj.2004.02.013
Shaw, 2004, Prognostic value of gated myocardial perfusion SPECT, J Nucl Cardiol, 11, 171, 10.1016/j.nuclcard.2003.12.004
Giri, 2002, Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease, Circulation, 105, 32, 10.1161/hc5001.100528
Ziemer, 2008, Random plasma glucose in serendipitous screening for glucose intolerance: screening for impaired glucose tolerance study 2, J Gen Intern Med, 23, 528, 10.1007/s11606-008-0524-1
Davidson, 2010, Correction to the 2010 report on the diagnosis and classification of diabetes, Diabetes Care, 33, e57, 10.2337/dc09-2368
Heisler, 2005, The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management, Diabetes Care, 28, 816, 10.2337/diacare.28.4.816
1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401
1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6
Home, 2007, Rosiglitazone evaluated for cardiovascular outcomes—an interim analysis, N Engl J Med, 357, 28, 10.1056/NEJMoa073394
Gerstein, 2006, Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial, Lancet, 368, 1096, 10.1016/S0140-6736(06)69420-8
Stettler, 2006, Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials, Am Heart J, 152, 27, 10.1016/j.ahj.2005.09.015
Duckworth, 2009, Glucose control and vascular complications in veterans with type 2 diabetes, N Engl J Med, 360, 129, 10.1056/NEJMoa0808431
Gerstein, 2008, Effects of intensive glucose lowering in type 2 diabetes, N Engl J Med, 358, 2545, 10.1056/NEJMoa0802743
Patel, 2008, Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, N Engl J Med, 358, 2560, 10.1056/NEJMoa0802987
Mosca, 2004, Evidence-based guidelines for cardiovascular disease prevention in women, J Am Coll Cardiol, 43, 900, 10.1016/j.jacc.2004.02.001
Pasternak, 2003, 34th Bethesda Conference: task force #1—identification of coronary heart disease risk: is there a detection gap?, J Am Coll Cardiol, 41, 1863, 10.1016/S0735-1097(03)00358-9
Mokdad, 2003, Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001, JAMA, 289, 76, 10.1001/jama.289.1.76
Huxley, 2006, Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies, BMJ, 332, 73, 10.1136/bmj.38678.389583.7C
Shaw, 2006, Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study, part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies, J Am Coll Cardiol, 47, S4, 10.1016/j.jacc.2005.01.072
Ford, 2002, Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey, JAMA, 287, 356, 10.1001/jama.287.3.356
Ramos, 2008, The prevalence of metabolic syndrome among US women of childbearing age, Am J Public Health, 98, 1122, 10.2105/AJPH.2007.120055
Pilote, 2007, A comprehensive view of sex-specific issues related to cardiovascular disease, CMAJ, 176, S1, 10.1503/cmaj.051455
Nasir, 2005, Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines, J Am Coll Cardiol, 46, 1931, 10.1016/j.jacc.2005.07.052
Lloyd-Jones, 2010, Heart disease and stroke statistics--2010 update: a report from the American Heart Association, Circulation, 121, e46
Mensah, 2005, State of disparities in cardiovascular health in the United States, Circulation, 111, 1233, 10.1161/01.CIR.0000158136.76824.04
Kwok, 2002, Prognostic value of the Duke treadmill score in the elderly, J Am Coll Cardiol, 39, 1475, 10.1016/S0735-1097(02)01769-2
LaRosa, 2005, Intensive lipid lowering with atorvastatin in patients with stable coronary disease, N Engl J Med, 352, 1425, 10.1056/NEJMoa050461